| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3898757 | Urology | 2015 | 5 Pages |
Abstract
CC relaxing effects induced by the adenosine A2A receptor agonist, LASSBio-1359, demonstrated in vitro and in vivo experimental protocols, represent a promise therapeutic option for the treatment of erectile dysfunction. Synergistic interaction of LASSBio-1359 with sildenafil suggests a combined use to reach a higher population of patients with erectile dysfunction.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Victor J.G. Moura, Allan K.N. Alencar, Jorge de Albuquerque Calasans-Maia, Jaqueline Soares da Silva, Carlos A.M. Fraga, Gisele Zapata-Sudo, Eliezer J. Barreiro, Roberto Takashi Sudo,